• Capabilities: Program Management
  • Sectors: Chemical and Life Science

Roche Pharmaceutical investment portfolio

Shanghai, China - Roche invested in a significant expansion of one of their Asia campuses as it sought to boost production capacity in order to respond to an increased demand for their products in both Asia and across the globe.

Schedule

targets hit

Energy

performance optimizied

Arcadis was appointed to ensure that the same high standards of Roche Pharmaceutical were carried through in the Phase II expansion of the operating site and increasing market demand for life-saving cancer drugs can be met.

In order to achieve this, we identified key individuals within Arcadis, both from China and utilizing Arcadis talent from around the globe, to supply expert resources in Project Management, Document Control, Scheduling, Lead Engineer and Quality Controls, assisting Roche Pharmaceutical to meet its goals.

Through effective communication and coordination among project teams, we ensured the aggressive schedule targets were met. The project was delivered to international construction quality standards while remaining in budget. All this was achieved while optimizing energy performance and minimizing environmental impact.


"The level of knowledge and insight Arcadis could provide by integrating the understanding of business needs with project management and engineering skills is crucial for the success of our Site Master Plan Projects. By making it possible to have key persons transfer from Europe to Asia following our manufacturing extension project, Arcadis went the extra mile we expect from truly global partners." 

Dr. Hans Tanner, Head Project Management China


Outcomes

Schedule

targets hit

Energy

performance optimizied

Delivered

within budget

Questions about this project

Matthias Boos

Sector Leader - Chemical & Pharmaceutical, Asia +86 21 6026 1300 Ask me a question